bio

Biogen Stock Price Jump 40% After FDA Approves Alzheimer’s Drug

Biogen Stock Price Jump 40% After FDA Approves Alzheimer’s Drug

Biogen Inc. (NASDAQ: BIIB) Alzheimer’s drug aducanumab or “Aduhelm” was approved by the Food and Drug Administration (FDA) this morning. Aduhelm is the first drug cleared by the FDA to help fight Alzheimer’s in almost 20 year..

Pfizer BioNTech COVID-19 Vaccine Confirmed to Lower Incidence Rates in Individuals

Pfizer BioNTech COVID-19 Vaccine Confirmed to Lower Incidence Rates in Individuals

Pfizer Inc. (NYSE: PFE), The Israel Ministry of Health and BioNTech SE (NASDAQ: BNTX) reported evidence that demonstrates lower incidence rates of COVID-19 disease in individuals that are vaccinated with BNT162b2.  The new data confirms previou..

iBio Provides Updates on COVID-19 Vaccine Program

iBio Provides Updates on COVID-19 Vaccine Program

iBio, Inc. (NYSE: IBIO) announced Thursday that immunization studies for its SARS-CoV-2 Virus-Like Particle (“VLP”) program (“IBIO-200”) are proceeding at Texas A&M University System (“TAMUS”) laboratories. Ac..

Hoth Therapeutics Shares Spike After Joint Venture for a Potential COVID-19 Vaccine

Hoth Therapeutics Shares Spike After Joint Venture for a Potential COVID-19 Vaccine

Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares spiked about 90% Monday morning after the biopharmaceutical company announced that it has reached an agreement with Voltron Therapeutics, Inc. to form a joint venture entity, to be named HaloVax, which w..

Pfizer and BioNTech to Collaborate on a Possible mRNA-based coronavirus vaccine

Pfizer and BioNTech to Collaborate on a Possible mRNA-based coronavirus vaccine

Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) today announced that the companies have agreed to a letter of intent regarding the co-development and distribution (excluding China) of a potential mRNA-based coronavirus vaccine aimed at preven..

BioNTech and Fosun Pharma Announced Strategic Partnership on Potential COVID-19 Vaccine

BioNTech and Fosun Pharma Announced Strategic Partnership on Potential COVID-19 Vaccine

BioNTech SE (NASDAQ: BNTX) and Shanghai Fosun Pharmaceutical (Group) Co., Ltd (“Fosun Pharma” or “Group”; Stock Symbol: 600196.SH, 02196.HK) announced today a strategic development and commercialization collaboration to advan..

BioXcel Therapeutics Announces Fourth Quarter and Fiscal Year 2019 Earnings

BioXcel Therapeutics Announces Fourth Quarter and Fiscal Year 2019 Earnings

BioXcel Therapeutics, Inc. (NASDAQ: BTAI) reported fourth quarter and full year ended December 31st, 2019 financial results.  BXCL501 is designed for the treatment of acute agitation.  The company initiated phase 3 trials for acute tr..